Lucid Diagnostics Commences Production of EsoCheck Devices with High-Volume Manufacturer Nov 09, 2022 8:25am EST
PAVmed to Hold a Business Update Conference Call and Webcast on November 15, 2022 Nov 03, 2022 8:25am EDT
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 14, 2022 Nov 02, 2022 8:25am EDT
PAVmed to Participate in the Lake Street 6th Annual Best Ideas Growth Conference and the A.G.P. Virtual MedTech Conference Aug 30, 2022 8:25am EDT
PAVmed Provides Business Update and Preliminary Second Quarter 2022 Financial Results Aug 16, 2022 4:40pm EDT
Lucid Diagnostics Provides Business Update and Preliminary Second Quarter 2022 Financial Results Aug 15, 2022 4:25pm EDT
Lucid Diagnostics Launches Stage II Lucid Test Center Expansion in California, Texas, Florida, and Ohio Aug 11, 2022 8:25am EDT
Newly Published American Gastroenterological Association Clinical Practice Update Supports Esophageal Precancer Screening Using Lucid Diagnostics’ EsoGuard® and EsoCheck® Technologies Aug 04, 2022 8:25am EDT
Lucid Diagnostics’ Laboratory Executes Four New Participating Provider Agreements Aug 02, 2022 8:25am EDT
